Insiders Updates Insider Sale Alert: Allogene Therapeutics Inc [ALLO] – Is it Time to sell? Allogene Therapeutics Inc’s recently made public that its Director MESSEMER DEBORAH M. unloaded Company’s shares for reported $52377.0 on Jun
Stock Earnings Citizens JMP downgrades Allogene Therapeutics Inc (ALLO) stock to a Mkt perform Allogene Therapeutics Inc’s recently made public that its Director MESSEMER DEBORAH M. unloaded Company’s shares for reported $52377.0 on Jun
Stock Earnings Examining the Potential Price Growth of Allogene Therapeutics Inc (ALLO) Allogene Therapeutics Inc’s filing revealed that its Director MESSEMER DEBORAH M. unloaded Company’s shares for reported $52377.0 on Jun 10
Stock Earnings Taking a Closer Look At Allogene Therapeutics Inc (ALLO) Following Its Recent Trade Allogene Therapeutics Inc’s filing revealed that its Director MESSEMER DEBORAH M. unloaded Company’s shares for reported $52377.0 on Jun 10